(Q30307291)

16 June 2017

title

Src family kinases and HER2 interactions in human breast cancer cell growth and survival (English)

1 reference

16 June 2017

1 reference

1 reference

Belsches-Jablonski AP

1 reference

16 June 2017

Biscardi JS

1 reference

16 June 2017

Peavy DR

1 reference

16 June 2017

Tice DA

1 reference

16 June 2017

Romney DA

1 reference

16 June 2017

Parsons SJ

1 reference

16 June 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

16 June 2017

1 reference

16 June 2017

1 reference

16 June 2017

1 reference

16 June 2017

page(s)

1465-1475

1 reference

Biologic effects of heregulin/neu differentiation factor on normal and malignant human breast and ovarian epithelial cells.

16 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

Characterization of human epidermal growth factor receptor and c-Src interactions in human breast tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

Tyrosine kinase signalling in breast cancer: epidermal growth factor receptor and c-Src interactions in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

Expression and tyrosine phosphorylation of EMS1 in human breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

Heregulin stimulates mitogenesis and phosphatidylinositol 3-kinase in mouse fibroblasts transfected with erbB2/neu and erbB3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

A neu acquaintance for erbB3 and erbB4: a role for receptor heterodimerization in growth signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

Distinct tyrosine autophosphorylation sites negatively and positively modulate neu-mediated transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

The neu-oncogene protein as a predictive factor for haematogenous metastases in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

Analysis of Grb7 recruitment by heregulin-activated erbB receptors reveals a novel target selectivity for erbB3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

In vitro drug sensitivity of normal peripheral blood lymphocytes and childhood leukaemic cells from bone marrow and peripheral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

Epiregulin binds to epidermal growth factor receptor and ErbB-4 and induces tyrosine phosphorylation of epidermal growth factor receptor, ErbB-2, ErbB-3 and ErbB-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

Direct linkage of EGF to its receptor: characterization and biological relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

Involvement of pp60c-src with two major signaling pathways in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

Potentiation of epidermal growth factor receptor-mediated oncogenesis by c-Src: implications for the etiology of multiple human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

Expression of c-erbB-2 in in situ and in adjacent invasive ductal adenocarcinomas of the female breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

Mammary tumors expressing the neu proto-oncogene possess elevated c-Src tyrosine kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

Src family protein tyrosine kinases: cooperating with growth factor and adhesion signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

ErbB tyrosine kinases and the two neuregulin families constitute a ligand-receptor network.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

Activation of ErbB4 by the bifunctional epidermal growth factor family hormone epiregulin is regulated by ErbB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

DNA synthesis induced by some but not all growth factors requires Src family protein tyrosine kinases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

Site-specific association of c-Src with epidermal growth factor receptor in A431 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

Epiregulin is a potent pan-ErbB ligand that preferentially activates heterodimeric receptor complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

Structural Basis of Interactions Between Epidermal Growth Factor Receptor and SH2 Domain Proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

Mechanism of biological synergy between cellular Src and epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

Bivalence of EGF-like ligands drives the ErbB signaling network

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

A simple method for the fluorescence analysis of nucleic acid-dye complexes in cytological preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

Immunohistochemical detection of c-erbB-2 protein in human benign and neoplastic prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

pp60c-src tyrosine kinase, myristylation, and modulatory domains are required for enhanced mitogenic responsiveness to epidermal growth factor seen in cells overexpressing c-src

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

Role of c-Src tyrosine kinase in EGF-induced mitogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

7 January 2021

c-Src, receptor tyrosine kinases, and human cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

7 January 2021

Differential signaling by the epidermal growth factor-like growth factors neuregulin-1 and neuregulin-2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

7 January 2021

Heregulin-stimulated signaling in rat pheochromocytoma cells. Evidence for ErbB3 interactions with Neu/ErbB2 and p85

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

7 January 2021

The biology of erbB-2/neu/HER-2 and its role in cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

7 January 2021

Inhibition of pp60c-Src reduces Bcl-XL expression and reverses the transformed phenotype of cells overexpressing EGF and HER-2 receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

7 January 2021

Integrin-mediated signaling in normal and malignant cells: a role of protein tyrosine kinases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

7 January 2021

Monoclonal antibodies to Rous sarcoma virus pp60src react with enzymatically active cellular pp60src of avian and mammalian origin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

7 January 2021

Immunohistochemical distribution of c-erbB-2 in in situ breast carcinoma--a detailed morphological analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

7 January 2021

Epidermal growth factor receptor expression as a prognostic indicator in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1204205

1 reference

Dimensions Publication ID

16 June 2017

1020109614

0 references

1 reference